Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Laposata
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Phenomena
Anatomy
Concepts & Ideas
Procedures
Living Beings
Disorders
Occupations
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
29
Cluette-Brown, Joanne
15
Van Cott, Elizabeth
12
Salem, Raneem
9
Soderberg, Britt
9
Freedman, Steven
7
Refaai, Majed
6
Zurier, Robert
6
Kabakibi, A
6
Best, Catherine
5
Hasaba, Ali
5
Furth, Emma
5
Saghir, Mouris
4
Ollero, Mario
4
Zaman, Munir
4
Warshaw, Andrew
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Laposata (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Avery Edwin G; Hilgenberg Alan D; Cambria Richard P; Beckerly Rena; Donnelly Anne M; Laposata Michael
Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer.
Anesthesia and analgesia 2009;108(4):1113-5.
-
2009: Piva Elisa; Sciacovelli Laura; Zaninotto Martina; Laposata Michael; Plebani Mario
Evaluation of effectiveness of a computerized notification system for reporting critical values.
American journal of clinical pathology 2009;131(3):432-41.
-
2008: Mischoulon David; Best-Popescu Catherine; Laposata Michael; Merens Wendelien; Murakami Jessica L; Wu Shirley L; Papakostas George I; Dording Christina M; Sonawalla Shamsah B; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(9):639-45.
-
2008: Al-Turkmani M Rabie; Andersson Charlotte; Alturkmani Ragheed; Katrangi Waddah; Cluette-Brown Joanne E; Freedman Steven D; Laposata Michael
A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA.
Journal of lipid research 2008;49(9):1946-54.
-
2008: Andersson Charlotte; Al-Turkmani M Rabie; Savaille Juanito E; Alturkmani Ragheed; Katrangi Waddah; Cluette-Brown Joanne E; Zaman Munir M; Laposata Michael; Freedman Steven D
Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.
Journal of lipid research 2008;49(8):1692-700.
-
2008: Alhomsi Khaled; Selig Martin; Sustic Tonci; Katrangi Eyad; Weissig Volkmar; Laposata Michael
Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl esters.
Alcoholism, clinical and experimental research 2008;32(3):534-43.
-
2007: Al-Turkmani M Rabie; Freedman Steven D; Laposata Michael
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Prostaglandins, leukotrienes, and essential fatty acids 2007;77(5-6):309-18.
-
2007: Peerschke Ellinor I B; Agrawal Yashpal; Alexander C Bruce; Bovill Edwin; Laposata Michael
Proposed research training guidelines for residents in laboratory medicine.
Clinics in laboratory medicine 2007;27(2):241-53; abstract v-vi.
-
2007: Wozniak Janet; Biederman Joseph; Mick Eric; Waxmonsky James; Hantsoo Liisa; Best Catherine; Cluette-Brown Joanne E; Laposata Michael
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):440-7.
-
2007: Everett Brendan M; Yeh Robert; Foo Shi Yin; Criss David; Van Cott Elizabeth M; Laposata Michael; Avery Edwin G; Hoffman William D; Walker Jennifer; Torchiana David; Jang Ik-Kyung
Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
The Annals of thoracic surgery 2007;83(2):592-7.
-
2007: Laposata Michael; Van Cott Elizabeth M; Lev Michael H
Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status.
The New England journal of medicine 2007;356(2):174-82.
-
2007: Batal Ibrahim; Ericsoussi Mhd-Bassel; Cluette-Brown Joanne E; O'Sullivan Brian P; Freedman Steven D; Savaille Juanito E; Laposata Michael
Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis.
Clinical chemistry 2007;53(1):78-84.
-
2007: Laposata Michael; Dighe Anand
"Pre-pre" and "post-post" analytical error: high-incidence patient safety hazards involving the clinical laboratory.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(6):712-9.
-
2006: Salem Raneem O; Laposata Michael
Activation and impairment of platelet function in vitro by fatty acid ethyl ester, a nonoxidative ethanol metabolite: effect of fatty acid ethyl esters on human platelets.
Alcoholism, clinical and experimental research 2006;30(12):2079-88.
-
2006: Popescu Gabriel; Ikeda Takahiro; Goda Keisuke; Best-Popescu Catherine A; Laposata Michael; Manley Suliana; Dasari Ramachandra R; Badizadegan Kamran; Feld Michael S
Optical measurement of cell membrane tension.
Physical review letters 2006;97(21):218101.
-
2006: Salem Raneem O; Laposata Michael; Rajendram Rajkumar; Cluette-Brown Joanne E; Preedy Victor R
The total body mass of fatty acid ethyl esters in skeletal muscles following ethanol exposure greatly exceeds that found in the liver and the heart.
Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(6):598-603.
-
2006: Melanson Stacy E F; Laposata Michael; Camargo Carlos A; Chen Annabel A; Tung Roderick; Krauser Dan; Anwaruddin Saif; Baggish Aaron; Cameron Renee; Sluss Patrick; Lewandrowski Kent B; Lee-Lewandrowski Elizabeth; Januzzi James L
Combination of D-dimer and amino-terminal pro-B-type natriuretic Peptide testing for the evaluation of dyspneic patients with and without acute pulmonary embolism.
Archives of pathology & laboratory medicine 2006;130(9):1326-9.
-
2006: Ollero Mario; Laposata Michael; Zaman Munir M; Blanco Paola G; Andersson Charlotte; Zeind John; Urman Yana; Kent Geraldine; Alvarez Juan G; Freedman Steven D
Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr-/- knockout mice.
Metabolism: clinical and experimental 2006;55(9):1192-200.
-
2006: Plebani Mario; Laposata Michael
Translational research involving new biomarkers of disease: a leading role for pathologists.
American journal of clinical pathology 2006;126(2):169-71.
-
2006: Foo Shi Yin; Everett Brendan M; Yeh Robert W; Criss David; Laposata Michael; Van Cott Elizabeth M; Jang Ik-Kyung
Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
American heart journal 2006;152(2):290.e1-7.
-
2006: Yeh Robert W; Everett Brendan M; Foo Shi-Yin; Dorer David J; Laposata Michael; Van Cott Elizabeth M; Jang Ik-Kyung
Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
The American journal of cardiology 2006;98(3):419-21.
-
2006: Alsfasser Guido; Warshaw Andrew L; Thayer Sarah P; Antoniu Bozena; Laposata Michael; Lewandrowski Kent B; Fernández-del Castillo Carlos
Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis.
Archives of surgery (Chicago, Ill. : 1960) 2006;141(7):670-6; discussion 676-7.
-
2006: Pysher Theodore J; Bach Philip R; Geaghan Sharon M; Hamilton Marilyn S; Laposata Michael; Lockitch Gillian; Brugnara Carlo; Coffin Cheryl M; Pasquali Marzia; Rinaldo Piero; Roberts William L; Rutledge Joe C; Ashwood Edward R; Blaylock Robert C; Campos Joseph M; Goldsmith Barbara; Jones Patricia M; Lim Megan; Meikle A Wayne; Perkins Sherrie L; Perry Deborah A; Petti Cathy A; Rogers Beverly B; Steele Paul E; Weiss Ronald L; Woods Gail
Teaching pediatric laboratory medicine to pathology residents.
Archives of pathology & laboratory medicine 2006;130(7):1031-8.
-
2006: Best Catherine A; Sarkola Taisto; Eriksson C J Peter; Cluette-Brown Joanne E; Laposata Michael
Increased plasma fatty acid ethyl ester levels following inhibition of oxidative metabolism of ethanol by 4-methylpyrazole treatment in human subjects.
Alcoholism, clinical and experimental research 2006;30(7):1126-31.
-
2006: Alhomsi Khaled; Laposata Michael
Fatty acid ethyl ester effects on interleukin-2 production, cyclic AMP synthesis, and calcium influx in human mononuclear cells.
Alcoholism, clinical and experimental research 2006;30(7):1121-5.
-
2006: Yoerger Danita M; Best Catherine A; McQuillan Brendan M; Supple Gregory E; Guererro J Luis; Cluette-Brown Joanne E; Hasaba Ali; Picard Michael H; Stone James R; Laposata Michael
Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery.
The American journal of pathology 2006;168(5):1435-42.
-
2006: Best Catherine A; Laposata Michael; Proios Veronia G; Szczepiorkowski Zbigniew M
Method to assess fatty acid ethyl ester binding to albumin.
Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(3):240-6.
-
2006: Alhomsi Khaled; Cluette-Brown Joanne E; Laposata Michael
Fatty acid ethyl esters in human mononuclear cells: Production by endogenous synthesis greatly exceeds the uptake of preformed ethyl esters.
Alcoholism, clinical and experimental research 2006;30(3):560-6.
-
2006: Salem R O; Laposata M
Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregation.
Journal of thrombosis and haemostasis : JTH 2006;4(1):275-6.
-
2005: Salem Raneem O; Cluette-Brown Joanne E; Laposata Michael
Fatty acid ethyl esters, nonoxidative ethanol metabolites, synthesis, uptake, and hydrolysis by human platelets.
Biochimica et biophysica acta 2005;1738(1-3):99-104.
-
2005: Blanco Paola G; Salem Raneem O; Ollero Mario; Zaman Munir M; Cluette-Brown Joanne E; Freedman Steven D; Laposata Michael
Ethanol administration to cystic fibrosis knockout mice results in increased fatty acid ethyl ester production.
Alcoholism, clinical and experimental research 2005;29(11):2039-45.
-
2005: Canavan Bridget; Salem Raneem O; Schurgin Sunita; Koutkia Polyxeni; Lipinska Izabella; Laposata Michael; Grinspoon Steven
Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation.
The Journal of clinical endocrinology and metabolism 2005;90(10):5779-85.
-
2005: Aleryani Samir Lutf; Cluette-Brown Joanne E; Khan Zia A; Hasaba Hasan; Lopez de Heredia Luis; Laposata Michael
Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction.
Clinica chimica acta; international journal of clinical chemistry 2005;359(1-2):141-9.
-
2005: Knoepp Stewart M; Laposata Michael
Aspirin resistance: moving forward with multiple definitions, different assays, and a clinical imperative.
American journal of clinical pathology 2005;123 Suppl():S125-32.
-
2005: Laposata Martha E; Laposata Michael
Children with signs of abuse: when is it not child abuse?
American journal of clinical pathology 2005;123 Suppl():S119-24.
-
2005: Laposata Martha E; Laposata Michael
Children with signs of abuse: when is it not child abuse?
American journal of clinical pathology 2005;123 Suppl():S119-24.
-
2005: Salem Raneem O; Laposata Michael
Effects of alcohol on hemostasis.
American journal of clinical pathology 2005;123 Suppl():S96-105.
-
2005: O'Sullivan Brian P; Linden Matthew D; Frelinger Andrew L; Barnard Marc R; Spencer-Manzon Michele; Morris James E; Salem Raneem O; Laposata Michael; Michelson Alan D
Platelet activation in cystic fibrosis.
Blood 2005;105(12):4635-41.
-
2005: Bisaga Adam; Laposata Michael; Xie Shan; Evans Suzette M
Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumption.
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(3):214-8.
-
2004: Laposata Martha E; Laposata Michael; Van Cott Elizabeth M; Buchner Dion S; Kashalo Mohammed S; Dighe Anand S
Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering.
Archives of pathology & laboratory medicine 2004;128(12):1424-7.
-
2004: Laposata Martha E; Laposata Michael; Van Cott Elizabeth M; Buchner Dion S; Kashalo Mohammed S; Dighe Anand S
Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering.
Archives of pathology & laboratory medicine 2004;128(12):1424-7.
-
2004: Dighe Anand S; Laposata Michael
Making the laboratory a partner in patient safety.
Clinical leadership & management review : the journal of CLMA 2004;18(6):356-60.
-
2004: Van Cott Elizabeth M; Laposata Michael; Hartnett M Elizabeth
Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(5):393-7.
-
2004: Blanco Paola G; Freedman Steven D; Lopez Mari C; Ollero Mario; Comen Elizabeth; Laposata Michael; Alvarez Juan G
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses.
American journal of obstetrics and gynecology 2004;190(5):1369-74.
-
2004: Laposata Michael
Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them?
Clinical chemistry 2004;50(3):471-2.
-
2004: Freedman Steven D; Blanco Paola G; Zaman Munir M; Shea Julie C; Ollero Mario; Hopper Isabel K; Weed Deborah A; Gelrud Andres; Regan Meredith M; Laposata Michael; Alvarez Juan G; O'Sullivan Brian P
Association of cystic fibrosis with abnormalities in fatty acid metabolism.
The New England journal of medicine 2004;350(6):560-9.
-
2003: Hasaba Ali; Cluette-Brown Joanne E; Laposata Michael
Stearic acid stimulates FA ethyl ester synthesis in HepG2 cells exposed to ethanol.
Lipids 2003;38(10):1051-5.
-
2003: Soderberg Britt L; Salem Raneem O; Best Catherine A; Cluette-Brown Joanne E; Laposata Michael
Fatty acid ethyl esters. Ethanol metabolites that reflect ethanol intake.
American journal of clinical pathology 2003;119 Suppl():S94-9.
-
2003: Laposata Michael; Johnson Stephen M
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days: an in vitro study.
Clinical therapeutics 2003;25(4):1219-25.
-
2003: Refaai Majed A; Van Cott Elizabeth M; Laposata Michael
The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
American journal of clinical pathology 2003;119(4):497-504.
-
2003: Hartnett M Elizabeth; Laposata Michael; Van Cott Elizabeth
Antiphospholipid antibody syndrome in a six-year-old female patient.
American journal of ophthalmology 2003;135(4):542-4.
-
2003: Refaai M A; Nguyen P N; Cluette-Brown J E; Laposata M
Ethyl arachidonate is the predominant fatty acid ethyl ester in the brains of alcohol-intoxicated subjects at autopsy.
Lipids 2003;38(3):269-73.
-
2003: Best Catherine A; Cluette-Brown Joanne E; Teruya Miho; Teruya Ami; Laposata Michael
Red blood cell fatty acid ethyl esters: a significant component of fatty acid ethyl esters in the blood.
Journal of lipid research 2003;44(3):612-20.
-
2003: Refaai Majed A; Laposata Michael; Van Cott Elizabeth M
Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia.
American journal of clinical pathology 2003;119(1):61-5.
-
2003: Best Catherine A; Laposata Michael
Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake.
Frontiers in bioscience : a journal and virtual library 2003;8():e202-17.
-
2002: Brenner Benjamin R; Nowak-Göttl Ulrike; Kosch Andrea; Manco-Johnson Marilyn; Laposata Michael
Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children.
Archives of pathology & laboratory medicine 2002;126(11):1296-303.
-
2002: Van Cott Elizabeth M; Laposata Michael; Prins Martin H
Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.
Archives of pathology & laboratory medicine 2002;126(11):1281-95.
-
2002: Laposata Michael; Hasaba Ali; Best Catherine A; Yoerger Danita M; McQuillan Brendan M; Salem Raneem O; Refaai Majed A; Soderberg Britt L
Fatty acid ethyl esters: recent observations.
Prostaglandins, leukotrienes, and essential fatty acids 2002;67(2-3):193-6.
-
2002: Werner Jens; Saghir Mouris; Warshaw Andrew L; Lewandrowski Kent B; Laposata Michael; Iozzo Renato V; Carter Edward A; Schatz Richard J; Fernández-Del Castillo Carlos
Alcoholic pancreatitis in rats: injury from nonoxidative metabolites of ethanol.
American journal of physiology. Gastrointestinal and liver physiology 2002;283(1):G65-73.
-
2002: Van Cott Elizabeth M; Soderberg Britt L; Laposata Michael
Hypercoagulability test strategies in the protein C and protein S pathway.
Clinics in laboratory medicine 2002;22(2):391-403.
-
2002: Nanji Amin A; Su Grace L; Laposata Michael; French Samuel W
Pathogenesis of alcoholic liver disease--recent advances.
Alcoholism, clinical and experimental research 2002;26(5):731-6.
-
2002: Van Cott Elizabeth M; Soderberg Britt L; Laposata Michael
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
Archives of pathology & laboratory medicine 2002;126(5):577-82.
-
2002: Kratz Alexander; Laposata Michael
Enhanced clinical consulting--moving toward the core competencies of laboratory professionals.
Clinica chimica acta; international journal of clinical chemistry 2002;319(2):117-25.
-
2002: Cunningham Mark T; Brandt John T; Laposata Michael; Olson John D
Laboratory diagnosis of dysfibrinogenemia.
Archives of pathology & laboratory medicine 2002;126(4):499-505.
-
2002: Ge Yinlin; Chen Zhihong; Kang Zhao B; Cluette-Brown Joanne; Laposata Michael; Kang Jing X
Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells.
Anticancer research 2002;22(2A):537-43.
-
2002: Meininger Gary; Hadigan Colleen; Laposata Michael; Brown Joanne; Rabe Jessica; Louca Joseph; Aliabadi Negar; Grinspoon Steven
Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
Metabolism: clinical and experimental 2002;51(2):260-6.
-
2002: Van Cott ElizabethM; Laposata Michael
Cysteine and venous thrombosis: a case report.
American journal of clinical pathology 2002;117(1):168.
-
2002: Refaai Majed A; Nguyen Phan N; Steffensen Thora S; Evans Richard J; Cluette-Brown Joanne E; Laposata Michael
Liver and adipose tissue fatty acid ethyl esters obtained at autopsy are postmortem markers for premortem ethanol intake.
Clinical chemistry 2002;48(1):77-83.
-
2001: Kratz A; Soderberg B L; Szczepiorkowski Z M; Dighe A S; Versalovic J; Laposata M
The generation of narrative interpretations in laboratory medicine: a description of service-specific sign-out rounds.
American journal of clinical pathology 2001;116 Suppl():S133-40.
-
2001: MacMillan D H; Soderberg B L; Laposata M
Regulations regarding reflexive testing and narrative interpretations in laboratory medicine.
American journal of clinical pathology 2001;116 Suppl():S129-32.
-
2001: Dighe A S; Soderberg B L; Laposata M
Narrative interpretations for clinical laboratory evaluations: an overview.
American journal of clinical pathology 2001;116 Suppl():S123-8.
-
2001: Soderberg B L; Laposata M
Fatty acid ethyl esters: markers of ethanol intake.
American clinical laboratory 2001;20(8):18-20.
-
2001: Werner J; Saghir M; Fernandez-del Castillo C; Warshaw A L; Laposata M
Linkage of oxidative and nonoxidative ethanol metabolism in the pancreas and toxicity of nonoxidative ethanol metabolites for pancreatic acinar cells.
Surgery 2001;129(6):736-44.
-
2001: Zybko W C; Cluette-Brown J E; Laposata M
Improved sensitivity and reduced sample size in serum fatty acid ethyl ester analysis.
Clinical chemistry 2001;47(6):1120-1.
-
2001: Salem R O; Refaai M A; Cluette-Brown J E; Russo J W; Laposata M
Fatty acid ethyl esters in liver and adipose tissues as postmortem markers for ethanol intake.
Clinical chemistry 2001;47(4):722-5.
-
2001: Hasaba A; Laposata M
The synthesis and secretion of fatty acid ethyl esters from HepG2 cells are stimulated by lipoproteins and albumin.
Alcoholism, clinical and experimental research 2001;25(3):338-43.
-
2001: Kang Z B; Ge Y; Chen Z; Cluette-Brown J; Laposata M; Leaf A; Kang J X
Adenoviral gene transfer of Caenorhabditis elegans n--3 fatty acid desaturase optimizes fatty acid composition in mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4050-4.
-
2001: Salem R O; Cluette-Brown J E; Hasaba A; Laposata M
Effect of specimen anticoagulant and storage on measurement of serum and plasma fatty acid ethyl ester concentrations.
Clinical chemistry 2001;47(1):126-7.
-
2000: Laposata M; Kabakibi A; Walden M P; Cluette-Brown J E; Nanji A A; Refaai M A; Werner J; Nanji A A
Differences in the fatty acid composition of fatty acid ethyl esters in organs and their secretions.
Alcoholism, clinical and experimental research 2000;24(10):1488-91.
-
1999: Soderberg B L; Sicinska E T; Blodget E; Cluette-Brown J E; Suter P M; Schuppisser T; Vetter W; Laposata M
Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples.
Clinical chemistry 1999;45(12):2183-90.
-
1999: Freedman S D; Katz M H; Parker E M; Laposata M; Urman M Y; Alvarez J G
A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13995-4000.
-
1999: Saghir M; Blodget E; Laposata M
The hydrolysis of fatty acid ethyl esters in low-density lipoproteins by red blood cells, white blood cells and platelets.
Alcohol (Fayetteville, N.Y.) 1999;19(2):163-8.
-
1999: Laposata M
Assessment of ethanol intake. Current tests and new assays on the horizon.
American journal of clinical pathology 1999;112(4):443-50.
-
1999: Laposata M
Fatty acid ethyl esters: current facts and speculations.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(5-6):313-5.
-
1999: Quinn D A; Fogel R B; Smith C D; Laposata M; Taylor Thompson B; Johnson S M; Waltman A C; Hales C A
D-dimers in the diagnosis of pulmonary embolism.
American journal of respiratory and critical care medicine 1999;159(5 Pt 1):1445-9.
-
1999: Goss K A; Alharethi R; Laposata M
Fatty acid ethyl ester synthesis in the preparation of scotch whiskey.
Alcohol (Fayetteville, N.Y.) 1999;17(3):241-5.
-
1999: Cunningham M T; Praestgaard J; Styer P E; Brandt J T; Fairweather R B; Laposata M; Olson J D; Sosolik R C; Triplett D A
A method for proficiency testing of small peer groups in the College of American Pathologists Coagulation Surveys.
Archives of pathology & laboratory medicine 1999;123(3):199-205.
-
1999: Laposata M
Fatty acid ethyl esters: nonoxidative ethanol metabolites with emerging biological and clinical significance.
Lipids 1999;34 Suppl():S281-5.
-
1998: Van Cott E M; Laposata M
Laboratory evaluation of hypercoagulable states.
Hematology/oncology clinics of North America 1998;12(6):1141-66, v.
-
1998: Laposata M; Green D; Van Cott E M; Barrowcliffe T W; Goodnight S H; Sosolik R C
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
Archives of pathology & laboratory medicine 1998;122(9):799-807.
-
1998: Dan L; Cluette-Brown J E; Kabakibi A; Laposata M
Quantitation of the mass of fatty acid ethyl esters synthesized by Hep G2 cells incubated with ethanol.
Alcoholism, clinical and experimental research 1998;22(5):1125-31.
-
1998: Kabakibi A; Morse C R; Laposata M
Fatty acid ethyl esters and HepG2 cells: intracellular synthesis and release from the cells.
Journal of lipid research 1998;39(8):1568-82.
-
1998: Kabakibi A; Vamvakas E C; Cannistraro P A; Szczepiorkowski Z M; Laposata M
Collagen-induced whole blood platelet aggregation in patients undergoing surgical procedures associated with minimal to moderate blood loss.
American journal of clinical pathology 1998;109(4):392-8.
-
1997: Kirby J E; Laposata M
The nature and extent of training activities in clinical pathology required for effective consultation on laboratory test selection and interpretation.
Archives of pathology & laboratory medicine 1997;121(11):1163-7.
-
1997: Saghir M; Werner J; Laposata M
Rapid in vivo hydrolysis of fatty acid ethyl esters, toxic nonoxidative ethanol metabolites.
The American journal of physiology 1997;273(1 Pt 1):G184-90.
-
1997: Van Cott E M; Muszbek L; Laposata M
Fatty acid acylation of platelet proteins.
Prostaglandins, leukotrienes, and essential fatty acids 1997;57(1):33-7.
-
1997: Werner J; Laposata M; Fernández-del Castillo C; Saghir M; Iozzo R V; Lewandrowski K B; Warshaw A L
Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol.
Gastroenterology 1997;113(1):286-94.
-
1997: Bird D A; Kabakibi A; Laposata M
The distribution of fatty acid ethyl esters among lipoproteins and albumin in human serum.
Alcoholism, clinical and experimental research 1997;21(4):602-5.
-
1997: Dan L; Laposata M
Ethyl palmitate and ethyl oleate are the predominant fatty acid ethyl esters in the blood after ethanol ingestion and their synthesis is differentially influenced by the extracellular concentrations of their corresponding fatty acids.
Alcoholism, clinical and experimental research 1997;21(2):286-92.
-
1996: Laposata M
What many of us are doing or should be doing in clinical pathology: a list of the activities of the pathologist in the clinical laboratory.
American journal of clinical pathology 1996;106(5):571-3.
-
1996: Zurier R B; Rossetti R G; Jacobson E W; DeMarco D M; Liu N Y; Temming J E; White B M; Laposata M
gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial.
Arthritis and rheumatism 1996;39(11):1808-17.
-
1996: Doyle K M; Cluette-Brown J E; Dube D M; Bernhardt T G; Morse C R; Laposata M
Fatty acid ethyl esters in the blood as markers for ethanol intake.
JAMA : the journal of the American Medical Association 1996;276(14):1152-6.
-
1996: Bird D A; Laposata M; Hamilton J A
Binding of ethyl oleate to low density lipoprotein, phospholipid vesicles, and albumin: a 13C NMR study.
Journal of lipid research 1996;37(7):1449-58.
-
1996: Hallaq Y; Szczepiorkowski Z M; Teruya J; Cluette-Brown J E; Laposata M
Stability of plasma nonesterified arachidonate in healthy individuals in fasting and nonfasting states.
Clinical chemistry 1996;42(5):771-3.
-
1996: Gorski N P; Nouraldin H; Dube D M; Preffer F I; Dombkowski D M; Villa E M; Lewandrowski K B; Weiss R D; Hufford C; Laposata M
Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics.
Alcoholism, clinical and experimental research 1996;20(2):268-74.
-
1996: Laposata M; Muszbek L
Thioesterification of platelet proteins with saturated and polyunsaturated fatty acids.
Lipids 1996;31 Suppl():S217-21.
-
1996: Bernhardt T G; Cannistraro P A; Bird D A; Doyle K M; Laposata M
Purification of fatty acid ethyl esters by solid-phase extraction and high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications 1996;675(2):189-96.
-
1996: Aleryani S; Kabakibi A; Cluette-Brown J; Laposata M
Fatty acid ethyl ester synthase, an enzyme for nonoxidative ethanol metabolism, is present in serum after liver and pancreatic injury.
Clinical chemistry 1996;42(1):24-7.
-
1995: Bird D A; Szczepiorkowski Z M; Trace V C; Laposata M
Low-density lipoprotein reconstituted with fatty acid ethyl esters as a physiological vehicle for ethyl ester delivery to intact cells.
Alcoholism, clinical and experimental research 1995;19(5):1265-70.
-
1995: Laposata M; Lewandrowski K B
Near patient blood glucose monitoring.
Archives of pathology & laboratory medicine 1995;119(10):926-8.
-
1995: Rossetti R G; Seiler C M; Laposata M; Zurier R B
Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids.
Clinical immunology and immunopathology 1995;76(3 Pt 1):220-4.
-
1995: Laposata M
Fatty acids. Biochemistry to clinical significance.
American journal of clinical pathology 1995;104(2):172-9.
-
1995: Heith A M; Morse C R; Tsujita T; Volpacelli S A; Flood J G; Laposata M
Fatty acid ethyl ester synthase catalyzes the esterification of ethanol to cocaine.
Biochemical and biophysical research communications 1995;208(2):549-54.
-
1995: Szczepiorkowski Z M; Dickersin G R; Laposata M
Fatty acid ethyl esters decrease human hepatoblastoma cell proliferation and protein synthesis.
Gastroenterology 1995;108(2):515-22.
-
1995: Laposata M; Szczepiorkowski Z M; Brown J E
Fatty acid ethyl esters: non-oxidative metabolites of ethanol.
Prostaglandins, leukotrienes, and essential fatty acids 1995;52(2-3):87-91.
-
1995: Teruya J; Cluette-Brown J; Szczepiorkowski Z M; Laposata M
Mode of transport of fatty acid to endothelial cells influences intracellular fatty acid metabolism.
Journal of lipid research 1995;36(2):266-76.
-
1994: Lee-Lewandrowski E; Laposata M; Eschenbach K; Camooso C; Nathan D M; Godine J E; Hurxthal K; Goff J; Lewandrowski K
Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing.
The American journal of medicine 1994;97(3):222-30.
-
1994: Doyle K M; Bird D A; al-Salihi S; Hallaq Y; Cluette-Brown J E; Goss K A; Laposata M
Fatty acid ethyl esters are present in human serum after ethanol ingestion.
Journal of lipid research 1994;35(3):428-37.
-
1994: Hallak H; Muszbek L; Laposata M; Belmonte E; Brass L F; Manning D R
Covalent binding of arachidonate to G protein alpha subunits of human platelets.
The Journal of biological chemistry 1994;269(7):4713-6.
-
1993: Muszbek L; Laposata M
Covalent modification of proteins by arachidonate and eicosapentaenoate in platelets.
The Journal of biological chemistry 1993;268(24):18243-8.
-
1993: Hallaq Y; Becker T C; Manno C S; Laposata M
Use of acetyl chloride/methanol for assumed selective methylation of plasma nonesterified fatty acids results in significant methylation of esterified fatty acids.
Lipids 1993;28(4):355-60.
-
1993: Muszbek L; Laposata M
Myristoylation of proteins in platelets occurs predominantly through thioester linkages.
The Journal of biological chemistry 1993;268(11):8251-5.
-
1992: McDonagh J; Fossel E T; Kradin R L; Dubinett S M; Laposata M; Hallaq Y A
Effects of tumor necrosis factor-alpha on peroxidation of plasma lipoprotein lipids in experimental animals and patients.
Blood 1992;80(12):3217-26.
-
1992: Furth E E; Sprecher H; Fisher E A; Fleishman H D; Laposata M
An in vitro model for essential fatty acid deficiency: HepG2 cells permanently maintained in lipid-free medium.
Journal of lipid research 1992;33(11):1719-26.
-
1992: Rubin D; Laposata M
Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation/desaturation, distribution among complex lipids, and conversion to eicosanoids.
Journal of lipid research 1992;33(10):1431-40.
-
1992: Lewandrowski K; Cheek R; Nathan D M; Godine J E; Hurxthal K; Eschenbach K; Laposata M
Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing.
The American journal of medicine 1992;93(4):419-26.
-
1991: Rubin D; Laposata M
Regulation of agonist-induced prostaglandin E1 versus prostaglandin E2 production. A mass analysis.
The Journal of biological chemistry 1991;266(35):23618-23.
-
1990: Laposata M; Teruya J
Reappraisal of preoperative coagulation testing.
American journal of clinical pathology 1990;94(6):795-6.
-
1990: Pullman-Mooar S; Laposata M; Lem D; Holman R T; Leventhal L J; DeMarco D; Zurier R B
Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid.
Arthritis and rheumatism 1990;33(10):1526-33.
-
1989: Furth E E; Hurtubise V; Schott M A; Laposata M
The effect of endogenous essential and nonessential fatty acids on the uptake and subsequent agonist-induced release of arachidonate.
The Journal of biological chemistry 1989;264(31):18494-501.
-
1989: Baker D G; Krakauer K A; Tate G; Laposata M; Zurier R B
Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid.
Arthritis and rheumatism 1989;32(10):1273-81.
-
1989: Muszbek L; Laposata M
Covalent modification of platelet proteins by palmitate.
Blood 1989;74(4):1339-47.
-
1989: Remaley A T; Kennedy J M; Laposata M
Evaluation of the clinical utility of platelet aggregation studies.
American journal of hematology 1989;31(3):188-93.
-
1989: Muszbek L; Laposata M
Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages.
The Journal of biological chemistry 1989;264(17):9716-9.
-
1989: Tate G; Mandell B F; Laposata M; Ohliger D; Baker D G; Schumacher H R; Zurier R B
Suppression of acute and chronic inflammation by dietary gamma linolenic acid.
The Journal of rheumatology 1989;16(6):729-34.
-
1989: Hartman E J; Omura S; Laposata M
Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
Prostaglandins 1989;37(6):655-71.
-
1988: Laposata M; Minda M; Capriotti A M; Hartman E J; Furth E E; Iozzo R V
Reversible phenotypic modulation induced by deprivation of exogenous essential fatty acids.
Laboratory investigation; a journal of technical methods and pathology 1988;59(6):838-47.
-
1988: Tate G A; Mandell B F; Karmali R A; Laposata M; Baker D G; Schumacher H R; Zurier R B
Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid.
Arthritis and rheumatism 1988;31(12):1543-51.
-
1988: Furth E E; Laposata M
Mass quantitation of agonist-induced arachidonate release and icosanoid production in a fibrosarcoma cell line. Effect of time of agonist stimulation, amount of cellular arachidonate, and type of agonist.
The Journal of biological chemistry 1988;263(31):15951-6.
-
1988: Capriotti A M; Furth E E; Arrasmith M E; Laposata M
Arachidonate released upon agonist stimulation preferentially originates from arachidonate most recently incorporated into nuclear membrane phospholipids.
The Journal of biological chemistry 1988;263(20):10029-34.
-
1988: Laposata M; Kaiser S L; Capriotti A M
Icosanoid production can be decreased without alterations in cellular arachidonate content or enzyme activities required for arachidonate release and icosanoid synthesis.
The Journal of biological chemistry 1988;263(7):3266-73.
-
1988: Connor A M; Laposata M
A rapid assay for platelet thromboxane production and its use in assessing prior aspirin ingestion.
American journal of clinical pathology 1988;89(2):216-21.
Sign-in to see more